Status:
UNKNOWN
Sensory Modulation Dysfunction and Posttraumatic Stress Disorder
Lead Sponsor:
Tel Aviv University
Conditions:
Posttraumatic Stress Disorder
Sensory Processing Disorder
Eligibility:
All Genders
18-28 years
Phase:
NA
Brief Summary
To explore the role of sensory modulation dysfunction (SMD) (i.e., a neurodevelopmental state altering the sensory perception, severely interfering with daily function) as a risk factor for posttrauma...
Detailed Description
Background and Aim: Posttraumatic stress disorder (PTSD) is interwoven with chronic pain, and the latter co-occurs with sensory modulation dysfunction (SMD). Moreover, SMD was found as a risk factor f...
Eligibility Criteria
Inclusion
- Intact or corrected vision
- Proficiency in Hebrew
Exclusion
- Neurological disorders
- Psychiatric disorders
- Neurodevelopmental disorders
- Substance use disorder
- Chronic pain
- Regular intake of medications.
- Cultural and societal backgrounds that might bias participant reaction to study protocol (i.e., nationality)
Key Trial Info
Start Date :
July 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05967962
Start Date
July 30 2023
End Date
December 31 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Tami Bar-Shalita
Tel Aviv, Israel